Advertisements

Sertralina Genfar

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Sertralina Genfar

What Type of Medicine is Sertralina Genfar?

Sertralina Genfar is a prescription-only medication containing the single active ingredient sertraline hydrochloride. This substance is a synthetic derivative manufactured for therapeutic use and is administered via the oral route. The medicine is classified as an antidepressant and belongs to the class known as Selective Serotonin Reuptake Inhibitors (SSRIs).

Its SSRI classification identifies its core action: to selectively affect the neurotransmitter serotonin in the brain. Clinical application focuses on the role of sertraline in restoring neurochemical balance. This pharmacological role supports the medicine's primary use in promoting emotional stability.

Pharmaceutical Form and General Therapeutic Role

The medicine is typically supplied in an oral solid form, such as a film-coated tablet. The core function of sertraline is the selective inhibition of neuronal serotonin (5-HT) uptake. This mechanism works by limiting the reabsorption of serotonin by nerve cells, which results in an increase in the neurotransmitter's functional availability within the central nervous system.

This focused action serves the drug’s general therapeutic purpose: to help regulate and stabilize mood and emotional processing. By concentrating its effects on the serotonin pathway, the medicine supports the establishment of a balanced signaling environment necessary for emotional equilibrium.

Regulatory References

  1. National Library of Medicine (NIH)
  2. National Institute of Health (NIH)
Advertisements

What side effects are possible with Sertralina Genfar?

Possible Side Effects and Safety Information

The official safety profile for Sertralina Genfar (sertraline hydrochloride) classifies potential adverse reactions based on their frequency of occurrence documented in clinical trials, predominantly affecting the gastrointestinal and nervous systems.

Commonly Documented Adverse Reactions

Adverse reactions classified as Very Common (occurring in ge 1 in 10 patients) include Nausea, Insomnia, Headache, Dry Mouth, and Diarrhea or loose stools. Effects categorized as Common (occurring in ge 1 in 100 patients) include Dizziness, Tremor, Somnolence, Decreased Libido, and Ejaculation Failure in men.

Serious Adverse Reactions and Safety Constraints

Regulatory documents highlight several serious, though often rare, reactions. These include the risk of developing Serotonin Syndrome (a potentially life-threatening condition associated with changes in mental status and neuromuscular abnormalities) and an increased risk of Abnormal Bleeding or hemorrhage. The medication is formally contraindicated for concurrent use with Monoamine Oxidase Inhibitors (MAOIs) due to the risk of Serotonin Syndrome.

Population-Specific and Time-Related Safety Notes

The safety profile includes specific considerations for certain patient groups. There is a documented increased risk of Suicidal Thoughts and Behaviors in pediatric, adolescent, and young adult patients (under 25 years of age), particularly noted at the start of treatment or following dose adjustments. Older adults may be at a higher documented risk for Hyponatremia (low serum sodium). Furthermore, official labeling notes that abrupt cessation may result in withdrawal-like symptoms (discontinuation syndrome).

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose Presentations and Clinical Manifestations

In cases of isolated Sertraline overdose, symptoms are typically reported as minor in nature, but all suspected overdoses require immediate medical attention. Documented presentations often involve the central nervous and cardiovascular systems, presenting as:

  • Drowsiness, tremor, agitation, confusion, or dizziness
  • Rapid heartbeat (tachycardia)
  • Gastrointestinal disturbances (nausea and vomiting)

Fatal outcomes have been reported, predominantly in cases involving the co-ingestion of Sertraline with other medications and/or alcohol. The risk of toxicity is significantly increased by such co-ingestion.

Serotonin Syndrome Risk

Overdose or co-administration with other serotonergic agents can lead to Serotonin Syndrome, a potentially life-threatening condition characterized by severe symptoms such as:

  • Muscle rigidity or twitching (myoclonus)
  • High body temperature (hyperthermia) and excessive sweating (diaphoresis)
  • Agitated delirium and confusion

Emergency Actions

There is no specific antidote for a Sertraline overdose. Treatment is supportive and focuses on maintaining a clear airway, ensuring adequate oxygenation and ventilation, and monitoring cardiac and other vital signs. Activated charcoal may be administered to reduce drug absorption. Due to the seriousness of Serotonin Syndrome and the risk associated with combined ingestions, any suspected overdose requires urgent referral to an emergency department or poison control center.

Advertisements

Therapeutic Uses of Sertralina Genfar

Main Therapeutic Uses

Sertralina Genfar is a medication belonging to the group of selective serotonin reuptake inhibitors (SSRIs). It is primarily used to manage various psychological and emotional health conditions by helping to balance serotonin levels in the brain.

Depressive Disorders

The medication is most commonly used for the treatment of major depressive disorder. It helps in alleviating symptoms such as persistent sadness, loss of interest in daily activities, and low energy levels. It is also indicated for preventing the recurrence of depressive episodes.

Anxiety and Panic Disorders

Sertralina Genfar is used to manage several types of anxiety-related conditions:

  • Panic Disorder: It helps reduce the frequency and intensity of panic attacks, including the physical symptoms and the fear of future attacks.
  • Social Anxiety Disorder: It is used to treat excessive self-consciousness and fear of social or performance situations.
  • Generalised Anxiety Disorder: It assists in managing chronic, excessive worry that interferes with daily life.

Obsessive-Compulsive Disorder (OCD)

In both adults and pediatric patients (typically aged 6-17), the medication is used to treat OCD. It helps reduce the persistence of unwanted thoughts (obsessions) and the urge to perform repetitive tasks (compulsions).

Post-Traumatic Stress Disorder (PTSD)

This medication is indicated for the treatment of PTSD, a condition that can develop after exposure to a traumatic event. It helps manage symptoms such as flashbacks, nightmares, and severe anxiety related to the event.

Premenstrual Dysphoric Disorder (PMDD)

Sertralina Genfar is used to treat the severe emotional and physical symptoms associated with PMDD, such as extreme irritability, mood swings, and tension occurring before the menstrual cycle.

Benefits and Expected Outcomes

When used as part of a comprehensive treatment plan, the medication aims to achieve several therapeutic goals:

  • Mood Stabilization: Helping to restore emotional balance and improve the overall outlook on daily life.
  • Reduction in Physical Symptoms of Anxiety: Assisting in the management of physical manifestations such as trembling, sweating, or rapid heartbeat associated with anxiety.
  • Improved Daily Functioning: By managing symptoms of depression and anxiety, the medication can help individuals return to their regular social, work, and family routines.
  • Control over Intrusive Thoughts: Providing a reduction in the frequency of distressing thoughts or repetitive behaviors in OCD and PTSD cases.
Advertisements

Eligibility and Restrictions for Use

Absolute Contraindications (Who Must Not Use)

Sertralina Genfar is contraindicated and must not be used in patients with known hypersensitivity to sertraline or any of its components. Its use is also strictly forbidden concurrently with, or within 14 days of discontinuing, Monoamine Oxidase Inhibitors (MAOIs), including linezolid and intravenous methylene blue. Concomitant administration with Pimozide or Thioridazine is also prohibited according to regulatory labeling.

Age-Group Eligibility and Limitations

Age Group Eligibility Status (Regulatory)
Adults (18+ years) Approved for all labeled indications.
Pediatric (6–17 years) Restricted to Obsessive-Compulsive Disorder (OCD) only.
Children (<6 years) Safety and effectiveness not established.
Older (Geriatric) Use is permitted, but caution is advised due to potential risks like hyponatremia.

Condition-Based and Organ-Function Restrictions

Use is not recommended in patients with severe hepatic impairment due to a lack of clinical data on safety. For patients with mild hepatic impairment, a lower or less frequent dose must be used, as the medicine's clearance is reduced. The regulatory label indicates that no dosage adjustment is typically necessary for patients with renal impairment. Use requires caution in patients with unstable epilepsy and in those with a history of mania or hypomania, where the medicine must be discontinued if a manic episode occurs.

Pregnancy and Lactation Eligibility

The medicine should be used during pregnancy only if the potential benefit justifies the potential risk, as determined by a risk-benefit assessment. Sertraline and its metabolite are excreted in human milk, requiring a careful assessment during lactation.

Advertisements

What should I know about interactions with other medicines?

Sertralina (Sertraline) can interact with a wide range of medications, increasing the potential for serious side effects. Patients must inform their healthcare provider of all prescription, over-the-counter, and herbal products they are taking.

️ Contraindicated Combinations (Must Not Be Used Together)

Other Medication Class Risk and Mechanism
Monoamine Oxidase Inhibitors (MAOIs) Risk of life-threatening Serotonin Syndrome. A washout period of at least 14 days is required when switching between Sertralina and an MAOI.
Pimozide Increases Pimozide blood levels, raising the risk of serious heart rhythm problems (QT prolongation).

Increased Bleeding Risk

Concomitant use with other medications that affect blood clotting can increase the risk of bleeding. This includes:

  • Anticoagulants (e.g., warfarin)
  • Antiplatelet drugs (e.g., aspirin)
  • Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) (e.g., ibuprofen, naproxen)

Serotonin Syndrome Risk

The risk of developing Serotonin Syndrome is elevated when Sertralina is combined with other serotonergic agents. While the overall risk is low, caution and monitoring are necessary. These agents include:

  • Triptans (migraine medications)
  • Other antidepressants (e.g., SSRIs, SNRIs, TCAs)
  • Certain opioids (e.g., tramadol, fentanyl)
  • Lithium
  • St. John's Wort

Additional interactions can occur with medications like phenytoin (Dilantin), as Sertralina may raise its levels, and with alcohol, which is not recommended due to potential enhancement of central nervous system effects. The liquid oral solution of Sertralina contains alcohol and is contraindicated with disulfiram (Antabuse).

Advertisements

Mechanism of Action

Mechanism of Action: Sertraline's Pharmacodynamics

Sertraline acts as a Selective Serotonin Reuptake Inhibitor (SSRI) by binding specifically to the Serotonin Transporter (SERT) protein located on presynaptic neuronal membranes. This interaction non-competitively blocks the reabsorption of the neurotransmitter serotonin (5-HT) from the synaptic cleft back into the neuron. The resultant sustained increase in extracellular 5-HT concentration increases the signal duration and frequency within the central serotonergic pathways.

Over time, this heightened signaling leads to regulatory adjustments in neuronal circuitry, including the desensitization of certain receptors and the secondary influence on the sigma1 receptor. This multistep mechanism promotes the production of neurotrophic factors and supports neuroplasticity (the capacity of the brain to form new connections). These long-term changes modulate the activity of specific neural circuits, defining the drug's resultant physiological activity patterns.

Advertisements

Dosage and Administration Information

Official Administration Instructions

Sertralina Genfar (sertraline) is administered orally and must be taken once daily, either in the morning or evening, and may be taken with or without food.

Dosing Rules and Titration

Initial and maximum dosages vary based on the treated condition and the patient's age. For most adult indications, the typical starting dose is 25 mg or 50 mg daily, and subsequent doses may be adjusted in 25 to 50 mg increments once weekly, up to a maximum daily dose of 200 mg. The recommended one-week interval between dose adjustments is based on the drug's 24-hour elimination half-life, ensuring steady-state plasma levels are reached before the next change.

Age Group Condition Constraint Starting Daily Dose
Adults General conditions 25 mg or 50 mg
Pediatric (6-12 years) Obsessive-Compulsive Disorder (OCD) only 25 mg
Pediatric (13-17 years) Obsessive-Compulsive Disorder (OCD) only 50 mg

For patients with mild hepatic impairment, the recommended starting and maximum daily dose is half the dosage used for patients without liver impairment. Use is not recommended for moderate or severe hepatic impairment.

Preparation and Missed Doses

  • Tablets/Capsules: Should be swallowed whole; do not crush, open, or chew them.
  • Oral Solution (Concentrate): This form must be diluted immediately prior to use. Measure the prescribed dose with the provided dropper and mix it into 4 ounces (120 mL) of water, ginger ale, lemon-lime soda, lemonade, or orange juice only. Consume the entire mixture right away. If a dose is missed, the general protocol is to skip the missed dose if it is almost time for the next scheduled dose, and to return to the regular dosing schedule without doubling the dose.

Treatment must not be stopped suddenly. When discontinuing, the dose should be gradually reduced over a period determined by the prescribing healthcare provider.

Advertisements

Recent Clinical Evidence

Research for Mood, Anxiety, and Trauma-Related Conditions

Research programs that was studied for Major Depressive Disorder (MDD), Panic Disorder (PD), Post-Traumatic Stress Disorder (PTSD), and Social Anxiety Disorder (SAD) primarily involved short-term randomized controlled trials (RCTs) in adult outpatients. These studies typically compared the medicine against a placebo to monitor patterns in groups of participants.

Outcomes used in research exploring how symptoms change over time were established measures that track symptom severity scores (such as the HAM-D scale) and overall global status assessments. Studies monitored patterns related to discontinuation rates and the frequency with which patients met a predetermined measurement on symptom scales during the treatment phase. Findings describe patterns observed in the studies over the initial weeks of the trials.


Evidence for Obsessive-Compulsive Disorder (OCD) and PMDD

Dedicated placebo-controlled trials have research examined Sertralina Genfar for Obsessive-Compulsive Disorder (OCD) and Premenstrual Dysphoric Disorder (PMDD). OCD studies included both adults and a separate program for pediatric patients (children and adolescents). This research explored changes in disorder-specific symptom scales.

PMDD research was studied for conditions associated with acute or disruptive episodes linked to the menstrual cycle. Researchers conducted randomized trials to explore two different treatment schedules: continuous daily use versus an intermittent schedule, with the studies examining patient-reported outcomes describing perceived discomfort and functional activity level.


Study Durations and Research Uncertainty

The primary acute trials were typically limited to 12 weeks or less. Beyond this, extended-duration studies have research examined the sustained observation of patterns and the potential for symptom return over periods up to 52 to 80 weeks. Despite these extensions, a key limitation remains: long-term effects are not fully established over many years of continuous use.

Research also indicates limitations in generalizability. The results apply only to the populations studied in the trials, which often did not include patients with high levels of comorbid conditions or complicated medical histories. Furthermore, data for certain groups remain insufficient, and research provides limited insight into certain patient-reported outcomes such as return to work or overall quality of life.

Key Studies & References

  1. Long-term sertraline treatment of children and adolescents with obsessive-compulsive disorder (52-week extension study)
  2. Sertraline - StatPearls (NCBI Bookshelf review article detailing indications, dosing, and safety overview)
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Sertralina Genfar (FAQ)


Q: What are the most common reasons a doctor prescribes Sertralina Genfar?

Sertraline is approved by regulatory bodies to address several conditions. These include Major Depressive Disorder (MDD), Obsessive-Compulsive Disorder (OCD), Panic Disorder (PD), Post-Traumatic Stress Disorder (PTSD), Social Anxiety Disorder (SAD), and Premenstrual Dysphoric Disorder (PMDD). The official indications define its primary uses in patient care.


Q: Is Sertralina Genfar the same as other sertraline brands?

Sertralina Genfar contains the active ingredient sertraline hydrochloride. Regulatory bodies like the U.S. FDA require all generic products to demonstrate bioequivalence to the original brand product. This means that both the generic and brand versions are expected to deliver the same amount of the active ingredient into the bloodstream at the same rate.


Q: Does Sertralina Genfar cause weight gain?

Changes in weight have been reported in clinical studies. While some patients may experience a small weight gain over extended use, other patients, particularly children, have reported decreased weight or a loss of appetite. These are potential changes observed during clinical studies.


Q: How long does it typically take to start feeling the effects of Sertralina Genfar?

According to official product information, it typically takes several weeks of continuous, regular use before the full therapeutic effect may be observed in research populations. However, some initial changes related to energy, sleep, or appetite may be noticed in the first one to two weeks of starting the medicine.


Q: Is it normal to feel more anxious when first starting Sertralina Genfar?

Official safety documents report that nervousness or agitation can occur as an adverse reaction. Regulatory agencies recommend monitoring for changes in behavior, including the emergence of suicidal thoughts or worsening of existing conditions, particularly during the initial few months of drug therapy.


Q: How is Sertralina Genfar different from fluoxetine?

Sertralina Genfar (sertraline) and fluoxetine both belong to the same class, called Selective Serotonin Reuptake Inhibitors (SSRIs), meaning they work in a similar way by affecting serotonin. The difference lies in their specific regulatory approvals, as the conditions they are approved to treat, such as PTSD or OCD in children, may vary between the two medicines.


Q: Can Sertralina Genfar affect sleep patterns?

Yes, official safety documents list both Insomnia (difficulty falling or staying asleep) and Somnolence (unusual drowsiness or sleepiness) as commonly reported side effects. Official administration instructions indicate the medicine may be taken in the morning or evening. The dosing schedule is determined by a healthcare provider.


Q: Can Sertralina Genfar affect my ability to drive or operate machinery?

Official patient information states that individuals should not drive, operate heavy machinery, or engage in other activities that require alertness until they are familiar with the medicine's effects. This warning is related to potential side effects like dizziness and somnolence.


Q: What should I know about switching from another antidepressant to Sertralina Genfar?

Switching between medicines in this class is typically managed with close supervision to reduce the risk of adverse reactions or discontinuation symptoms. General regulatory practice recommends close monitoring for symptoms during any transition and may involve a gradual reduction of the first medicine or a specific washout period, especially when switching from certain classes.


Q: Does Sertralina Genfar affect blood pressure?

The medicine is not primarily known for affecting blood pressure. However, some post-marketing reports have documented changes in blood pressure or heart rate. Regulatory documents note that caution is exercised in patient populations with pre-existing heart rhythm problems.


Q: Is Sertralina Genfar a controlled substance?

Sertraline is an SSRI class of medicine and is not classified as a controlled substance under U.S. regulatory schedules. This classification is due to its low risk for abuse or dependence.


Q: Does the time of day matter when taking Sertralina Genfar?

Official administration instructions state the medicine must be taken once daily and may be taken in either the morning or the evening. A healthcare provider determines the ideal time for administration.


Q: How quickly can side effects appear after starting Sertralina Genfar?

Common side effects like nausea or diarrhea may be observed early in the course of treatment. Warnings about serious effects, such as the increased risk of suicidal thoughts in young adults, are specifically noted as being highest during the initial few months of therapy or following dose adjustments.


Q: Can men and women expect different side effects from Sertralina Genfar?

Yes, regulatory data reports differences in the frequency of certain sexual adverse reactions based on sex. For example, ejaculation failure is reported specifically in men, while decreased libido (sex drive) is reported in both men and women, often at different frequency rates.


Q: How is Sertralina Genfar eliminated from the body?

The medicine is eliminated from the body primarily through hepatic metabolism, meaning it is broken down by the liver. After metabolism, the resulting compounds are mostly cleared through the urine and feces.


Q: Are there any known interactions with herbal supplements and Sertralina Genfar?

Regulatory documents explicitly name the herbal supplement St. John's Wort as a serotonergic agent that can increase the risk of a serious reaction called Serotonin Syndrome. The full disclosure of all prescription, over-the-counter, and herbal products is a standard recommendation in official product labeling.


Q: What is the risk of dependence or addiction with Sertralina Genfar?

The medicine is not classified as a controlled substance due to a low risk of abuse. However, prolonged use can result in the development of physical dependence. The official label notes that when discontinuing, the dose should be gradually reduced, which is done to minimize the possibility of withdrawal-like symptoms.


Q: What are the general expectations for benefits when starting Sertralina Genfar?

The general therapeutic role of the medicine is to help regulate and stabilize mood and emotional processing over time by increasing the functional availability of the neurotransmitter serotonin. Official patient information indicates that the full range of therapeutic changes may take several weeks to be observed.


Q: How long is a typical treatment course with Sertralina Genfar?

Regulatory research has examined its use in acute trials lasting up to 12 weeks and in extended studies lasting up to 52 to 80 weeks to assess sustained benefit. The duration of treatment is an individualized decision made by a healthcare provider.

Advertisements

How should Sertralina Genfar be stored and disposed of?

Official Storage and Handling Requirements

The regulatory labeling for sertraline hydrochloride tablets and capsules requires storage at Controlled Room Temperature, typically 20 C to 25 C (68 F to 77 F), with permitted excursions up to 30 C (86 F). The medication must be kept in its original container, tightly closed, and protected from excess heat and moisture to preserve its stability. It is also explicitly stated that the product must be secured out of the sight and reach of children.

Official Disposal Rules

Expired or unused sertraline should be discarded using a drug take-back program or other authorized collection sites as the preferred disposal method. If such programs are not readily available, the medication can be mixed with an unappealing substance like dirt or used coffee grounds, placed in a sealed bag or container, and then thrown into household trash. Regulatory bodies advise against flushing sertraline down the toilet, as it is not on the list of medicines recommended for sink or toilet disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Sertralina Genfar found in:

A-Z Index: